Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Activ Surgical launches robotic surgery AI software

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

NAMSA and Lexitas Launch Ophthalmic MedTech...

NAMSA and Lexitas Pharma Services have entered into a...

Husky and SEM Plastik Announce Strategic...

Husky Technologiesโ„ข, a global leader in precision injection molding...

Europeโ€™s Tissue Industry Supports Millions of...

New data highlights the sectorโ€™s economic contribution and essential...

Activ SurgicalActiv Surgical said it is launching ActivEdge, an artificial-intelligence and machine-learning platform designed to improve surgical procedures and outcomes. The Boston-based company said it will be available initially in the U.S. and next year worldwide.

Activ Surgical said it will initially focus on promoting the new software for the most common laparoscopic procedures, including cholecystectomy, colectomy, hysterectomy and gastrectomy, where blood flow and critical structure identification are crucial to optimal outcomes.

The companyโ€™s product portfolio is built on the ActiveEdge platform and includes hardware-agnostic imaging software and computer-driven guidance systems, both for scopes and robots, to improve situational awareness and real-time imaging during surgical procedures and enable safe tissue access.

โ€œThe future of surgery is collaborative, with human judgment and wisdom augmented by robotics precision,โ€ said Activ Surgical CEO Todd Usen in a news release. โ€œWith nearly 400,000 deaths in the U.S. every year due to avoidable medical errors, our surgical intelligence platform is designed to dramatically improve outcomes, safety and accessibility by arming surgeons with real-time information to make better informed decisions.โ€

The most commonly employed surgical imaging process, ICG, uses fluorescent dye invented more than 70 years ago and does not offer real-time, objective physiologic information to surgeons when they need it during procedures, according to Dr. Peter Kim, the companyโ€™s co-founder and chief science officer.

โ€œThe next frontier in surgery is advanced imaging, led by innovation from companies like Activ Surgical, to enable intraoperative imaging and image overlays, guided by machine learning,โ€ added Dr. Vipul Patel, medical director of both the Global Robotics Institute at Advent Health Celebration and of the Advent Health Cancer Institute urologic oncology program (Orlando, Fla.) . โ€œThe potential for Activ Surgical to use AI and machine learning to inform robotics-assisted surgery, bringing together the best of human judgment and wisdom augmented by robotics precision, is a game-changer in helping the surgical community achieve better outcomes.โ€

MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

NAMSA and Lexitas Launch Ophthalmic MedTech Partnership

NAMSA and Lexitas Pharma Services have entered into a...

Taiwanโ€™s MedTech Ecosystem Attracts Global Interest Ahead of Medical Taiwan 2026

As healthcare systems worldwide accelerate digital transformation, international buyers...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป